<https://rdf.molmedb.upol.cz/reference/ref4274> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00085>,
		<https://identifiers.org/molmedb/MM495174>;
	<http://purl.org/ontology/bibo/pmid> "33887912"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495184>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.0c01938"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>;
	<http://purl.org/dc/terms/bibliographicCitation> "Kim W, Kang JA, Park M, Jeong PH, Kim YJ, Cho Y, Park SG, Kim YC.: Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents. J Med Chem, Volume 64 (9), 2021"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM495173> .
<https://rdf.molmedb.upol.cz/interaction/int1022167> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4274> .
<https://rdf.molmedb.upol.cz/interaction/int1021481> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4274> .
<https://rdf.molmedb.upol.cz/interaction/int1021482> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4274> .
<https://rdf.molmedb.upol.cz/interaction/int1021492> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4274> .